Genelex Receives Innovative Technology Designation from Vizient, Inc. for YouScript® Software
Genelex receives Innovative Technology Designation from Vizient, Inc. for YouScript® software that reduces ER visits & hospitalizations with improved, gene-based medication management. Designation recognizes the development of new solutions that benefit the health care industry. - January 30, 2016
Breast Cancer Patients Have Options, Yet Many Are Not Being Informed
Over 30,000 breast cancer survivors are being put at unnecessary risk of a breast cancer recurrence due to limited awareness of a genetic test that can determine if tamoxifen is the most effective treatment for them. - October 22, 2009
Press Releases 1 - 2 of 2